Combination Therapy (in the Treatment of Peyronie’s Disease)

[1]  Aless,et al.  Pentoxifylline Associated with Other Antioxidants (Multimodal Therapy) on Patients with Peyronie's Disease. Results of a Controlled Study , 2014 .

[2]  G. Morgia,et al.  Combination of intralesional verapamil and oral antioxidants for Peyronie's disease: a prospective, randomised controlled study , 2014, Andrologia.

[3]  H. McIlleron,et al.  Redefining Multidrug-Resistant Tuberculosis Based on Clinical Response to Combination Therapy , 2014, Antimicrobial Agents and Chemotherapy.

[4]  M. Rashidi,et al.  Combination therapy increases the efficacy of docetaxel, vinblastine and tamoxifen in cancer cells. , 2014, Journal of cancer research and therapeutics.

[5]  R. Alvaro,et al.  Long-term multimodal therapy (verapamil associated with propolis, blueberry, vitamin E and local diclofenac) on patients with Peyronie's disease (chronic inflammation of the tunica albuginea). Results of a controlled study. , 2013, Inflammation & allergy drug targets.

[6]  L. Levine.  Peyronie’s disease: A contemporary review of non-surgical treatment , 2013, Arab journal of urology.

[7]  L. Levine.  Peyronie’s disease: contemporary review of non-surgical treatment , 2013, Translational andrology and urology.

[8]  R. Alvaro,et al.  Peironimev-Plus® in the treatment of chronic inflammation of tunica albuginea (Peyronie's disease). results of a controlled study. , 2013, Inflammation & allergy drug targets.

[9]  Jung Tae Kim,et al.  Efficacy of vitamin E in the conservative treatment of Peyronie's disease: legend or reality? A controlled study of 70 cases , 2013, Andrology.

[10]  R. Alvaro,et al.  Effectiveness of antioxidants (propolis, blueberry, vitamin E) associated with verapamil in the medical management of Peyronie's disease: a study of 151 cases , 2012, International journal of andrology.

[11]  P. Geavlete,et al.  Pharmacological therapy in patients diagnosed with Peyronie's disease , 2012, Journal of medicine and life.

[12]  L. Levine,et al.  Combination of penile traction, intralesional verapamil, and oral therapies for Peyronie's disease. , 2012, The journal of sexual medicine.

[13]  L. Levine,et al.  Review of non-surgical treatment options for Peyronie's Disease , 2012, International Journal of Impotence Research.

[14]  R. Herwig,et al.  Peyronie's Disease: Nonsurgical Therapy Options. , 2011, Reviews in urology.

[15]  J. Cortés-González,et al.  Tratamiento conservador de la enfermedad de Peyronie: colchicina versus colchicina ms vitamina E , 2010 .

[16]  S. Glina,et al.  [Conservative treatment of Peyronie's disease: colchicine vs. colchicine plus vitamin E]. , 2010, Actas urologicas espanolas.

[17]  F. Ramos,et al.  Enfermedad de la Peyronie. Tratamiento con interferon y láser. , 2008 .

[18]  L. Levine,et al.  Non-surgical therapy of Peyronie's disease. , 2008, Asian journal of andrology.

[19]  M. Çakan,et al.  Does smoking change the efficacy of combination therapy with vitamin E and colchicines in patients with early-stage Peyronie's disease? , 2006, Archives of andrology.

[20]  M. L. Vallejo,et al.  Combined treatment with vitamin E and colchicine in the early stages of Peyronie's disease , 2003 .

[21]  G. Cavallini,et al.  Oral propionyl‐l‐carnitine and intraplaque verapamil in the therapy of advanced and resistant Peyronie's disease , 2002, BJU international.

[22]  A. Natali,et al.  Peyronie’s Disease: Prevalence and Association with Cigarette Smoking , 2001, European Urology.

[23]  M. Lykourinas,et al.  The Use of Betamethasone and Hyaluronidase Injections in the Treatment of Peyronie?s Disease , 2000, Scandinavian journal of urology and nephrology.

[24]  S. Pastorini,et al.  [The therapy of plastic penile induration using superoxide dismutase per os and injection combined with vasoactive intracavernous pharmacotherapy]. , 1991, Minerva urologica e nefrologica = The Italian journal of urology and nephrology.

[25]  A. Lazarus.  The Practice of Multimodal Therapy: Systematic, Comprehensive, and Effective Psychotherapy , 1989 .

[26]  Novak GIa.  [Conservative treatment of Peyronie's disease with vitamin E and hydrocortisone]. , 1984 .

[27]  B. Nielsen,et al.  [Peyronie's disease treated with K-para-aminobenzoate and vitamin E]. , 1979, Ugeskrift for laeger.

[28]  M. Turri,et al.  Rifampicin-ethambutol in the treatment of resistant pulmonary tuberculosis. , 1970, German medical monthly.

[29]  M. Turri,et al.  [Combined rifampicin-ethambutol therapy of resistent pulmonary tuberculosis. Effectiveness of various rifampicin doses in combination with ethambutol]. , 1970, Deutsche medizinische Wochenschrift.

[30]  Burford Ce,et al.  Combined Therapy for Peyronie’s Disease , 1957 .

[31]  O. Ferulano.  [Effect of circular electrolysis combined with medical treatment (wydase and vitum E) in delayed plastic induration of penis; hypothesis on etiology and pathogenesis and clinical aspects]. , 1955, Giornale italiano di chirurgia.

[32]  D. Shapiro.  Combination chemotherapy with 8-azaguanine and sex hormones on a mouse mammary carcinoma. , 1952, Cancer research.

[33]  A. Gellhorn,et al.  Combinations of chemical compounds in experimental cancer therapy. , 1951, Cancer research.

[34]  H. Skipper,et al.  Carbamates in the chemotherapy of leukemia. VIII. Overall tracer studies on carbonyl-labeled urethan, methylene-labeled urethan, and methylene-labeled ethyl alcohol. , 1951, Cancer research.

[35]  A. Kristenson.  Treatment of cavernous pulmonary tuberculosis with a combination of chemotherapy and antibiotics. , 1950, Acta tuberculosea Scandinavica. Supplementum.

[36]  H. Skipper,et al.  Carbamates in the chemotherapy of leukemia. V. observation of a possible antileukemic synergism between urethane and methyl‐bis (β‐chloroethyl) amine , 1949 .

[37]  H. Madsen.  Combination promin and streptomycin therapy for tuberculosis. , 1948, Diseases of the chest.